ヘルスケア3Dプリンティングの世界市場規模：製品別、技術別、用途別、地域別、範囲および予測

ヘルスケア3Dプリンティングの市場規模と予測

ヘルスケア3Dプリンティング市場規模は、2023年に33億8,000万米ドルと評価され、2024年から2031年にかけて19.29%のCAGRで成長し、2031年には122億6,000万米ドルに達すると予測されています。

ヘルスケア3Dプリンティングは、積層造形法を用いてパーソナライズされた医療品やインプラントを製造するプロセスです。この技術により、整形外科、人工関節、手術計画における正確で患者固有のソリューションが可能になります。

この技術は、インプラント、人工関節、手術前計画用の解剖学的モデルの作成に使用されます。パーソナライズされたインプラントや手術器具は、患者の転帰を向上させ、手術手順を簡素化します。

将来の応用としては、人工器官やインプラントに加えて、組織や臓器のバイオプリンティングがあります。再生医療や個別化治療の進歩をもたらし、医療疾患の対処法や治療法を一変させる可能性があります。

ヘルスケア3Dプリンティングの世界市場力学

主な市場促進要因

技術的進歩：3Dプリンティング技術の進歩により、精度、スピード、材料の可能性が向上し、個別化インプラント、人工器官、手術計画での用途が拡大することで成長が促進されます。

個別化医療に対する需要の高まり：人々が個別化されたヘルスケアソリューションを求めるようになり、個々の患者の要求に適応したカスタムメイドのインプラントや人工関節の需要が高まっており、これが市場の成長を促進しています。

慢性疾患の増加：慢性疾患の蔓延が増加しており、パーソナライズされた3Dプリント医療機器のような高度な代替治療が必要とされています。

主な課題

規制上の障害：3Dプリント医療機器に関するさまざまな規制や認可の取得は困難で時間がかかるため、市場開拓や製品開発の妨げとなります。

高コスト：3Dプリント技術や材料の初期コストが高いため、特にリソースに制約のあるヘルスケア環境では、アクセスや普及が制限される可能性があります。

材料の制限：ヘルスケアにおける3Dプリンティングで利用可能な材料の数は依然として限られており、プリントされた医療機器やインプラントの機能性や寿命が低下します。

品質と標準化：一貫した品質を維持し、3Dプリント医療機器の厳しい要件を満たすことは難しく、信頼性と臨床現場での普遍的な採用が損なわれます。

主要動向：

バイオプリンティングの進歩：バイオプリンティングの進歩により、複雑な組織や臓器のプロトタイプの作成が可能になり、再生医療の限界を押し広げつつあります。

デジタルヘルス技術との統合：3Dプリンティングを画像やCADソフトウェアなどのデジタルヘルスツールと組み合わせることで、医療機器の製造や手術計画の精度が向上します。

新興市場での拡大：新興市場におけるヘルスケア投資の増加が3Dプリンティング産業の成長を促進し、最新の医療技術への世界のアクセスを増加させています。

目次

第1章 世界のヘルスケア3Dプリンティング市場：イントロダクション

• 市場のイントロダクション
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 ヘルスケア3Dプリンティングの世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 ヘルスケア3Dプリンティングの世界市場：技術別

• 概要
• シリンジベース
• 磁気浮上式
• レーザーベース
• インクジェットベース

第6章 ヘルスケア3Dプリンティングの世界市場：用途別

• 概要
• 溶融堆積モデリング（FDM）
• 選択的レーザー焼結（SLS）
• ステレオリソグラフィー

第7章 ヘルスケア3Dプリンティングの世界市場：エンドユーザー別

• 概要
• バイオセンサー
• 医療用
• 医薬品
• 補綴およびインプラント
• 組織と臓器の生成
• 歯科

第8章 ヘルスケア3Dプリンティングの世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 世界のヘルスケア3Dプリンティング市場：競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第10章 企業プロファイル

• Cyfuse Biomedical
• Aprecia Pharmaceuticals
• Aspect Biosystems
• Bio 3D Technologies
• BioBots
• 3Dynamics Systems
• Envision TEC
• Luxexel
• Materialise NV
• Nano3D Biosciences
• Oceanz
• Organovo Holdings, Inc.
• regenHU
• Digilab

第12章 付録

• 関連調査

Healthcare 3D Printing Market Size And Forecast

Healthcare 3D Printing Market size was valued at USD 3.38 Billion in 2023 and is projected to reach USD 12.26 Billion by 2031 growing at a CAGR of 19.29% from 2024 to 2031.

Healthcare 3D printing is the process of making personalized medical items and implants using additive manufacturing. This technique allows for precise, patient-specific solutions in orthopedics, prostheses and surgical planning.

It is used to create implants, prostheses and anatomical models for pre-surgical planning. Personalized implants and surgical instruments enhance patient outcomes and simplify surgical procedures.

Future applications include bioprinting tissues and organs, in addition to prostheses and implants. It offers advances in regenerative medicine and individualized treatment, which could transform how medical diseases are handled and treated.

Global Healthcare 3D Printing Market Dynamics

The key market dynamics that are shaping the global healthcare 3D printing market include:

Key Market Drivers:

Technological Advancements: Advancements in 3D printing technology improve precision, speed and material possibilities, boosting growth by expanding its uses in personalized implants, prostheses and surgical planning.

Rising Demand for Personalized Medicine: As people want personalized healthcare solutions, there is a greater demand for custom-made implants and prostheses adapted to individual patient demands, which is driving market growth.

Growing Incidence of Chronic Diseases: Chronic disease prevalence is increasing, necessitating sophisticated treatment alternatives such as personalized 3D-printed medical equipment, which is driving market demand.

Key Challenges:

Regulatory Obstacles: Navigating several regulations and securing clearances for 3D-printed medical equipment can be difficult and time-consuming, hindering market penetration and product development.

High Costs: High initial costs for 3D printing technology and materials might limit accessibility and uptake, particularly in resource-constrained healthcare settings.

Material Limitations: The number of materials available for 3D printing in healthcare remains limited, reducing the functionality and lifetime of printed medical devices and implants.

Quality and Standardization: Maintaining consistent quality and meeting demanding requirements for 3D-printed medical devices is difficult, compromising reliability and universal adoption in clinical settings.

Key Trends:

Advancements in Bioprinting: Bioprinting advances are allowing for the creation of complex tissues and organ prototypes, pushing the boundaries of regenerative medicine.

Integration with Digital Health Technologies: Combining 3D printing with digital health tools like imaging and CAD software improves precision in medical device manufacture and surgery planning.

Expansion in Emerging Markets: Rising healthcare investments in emerging markets are driving the growth of the 3D printing industry, increasing global access to modern medical technology.

Global Healthcare 3D Printing Market Regional Analysis

Here is a more detailed regional analysis of the global healthcare 3D printing market:

North America:

According to Verified Market Research, North America is expected to dominate the global healthcare 3D printing market.

North America is predicted to dominate the worldwide healthcare 3D printing market due to its strong technological infrastructure, considerable R&D investments and high healthcare spending.

The region's strong emphasis on innovation and individualized medicine, combined with a solid healthcare system and early embrace of cutting-edge technologies, puts it as a pioneer in the development and implementation of 3D printing solutions in healthcare.

Asia Pacific:

According to Verified Market Research, Asia Pacific is fastest growing region in global healthcare 3D printing market.

Asia-Pacific is the fastest-growing region in the worldwide healthcare 3D printing market, owing to rapid advances in medical technology, increasing healthcare investments and rising demand for individualized medical solutions.

The region benefits from expanded healthcare infrastructure and government efforts that promote innovation. increasing usage of 3D printing in medical applications, such as prosthetics and implants, fuels growth, establishing Asia-Pacific as a prominent player in market expansion.

Global Healthcare 3D Printing Market: Segmentation Analysis

The Global Healthcare 3D Printing Market is segmented based on Product, Technology, Application and Geography.

Healthcare 3D Printing Market, By Technology

• Syringe Based
• Magnetic Levitation
• Laser Based
• Inkjet Based

Based on Technology, the Global Healthcare 3D Printing Market is separated into Syringe Based, Magnetic Levitation, Laser Based, and Inkjet Based. Laser-based technology leads the worldwide healthcare 3D printing market due to its precision, adaptability and capacity to create high-quality, complicated structures for medical implants and equipment.

Healthcare 3D Printing Market, By Application

• Fused Deposition Modelling (FDM)
• Selective Laser Sintering (SLS)
• Stereolithography

Based on Application, Global Healthcare 3D Printing Market is divided into Fused Deposition Modelling (FDM), Selective Laser Sintering (SLS), and Stereolithography. Fused Deposition Modeling (FDM) leads the global healthcare 3D printing industry due to its low cost and versatility in producing medical implants, prosthetics and anatomical models.

Healthcare 3D Printing Market, By End-User

• Biosensors
• Medical
• Pharmaceuticals
• Prosthetics and Implants
• Tissue and Organ Generation
• Dental

Based on End-User, Global Healthcare 3D Printing Market is divided into Biosensors, Medical, Pharmaceuticals and Dental. The worldwide healthcare 3D printing market is dominated by prosthetics and implants due to rising demand for individualized medical devices and improvements in materials and technology for tailored patient solutions.

Healthcare 3D Printing Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on the Geography, the Global Healthcare 3D Printing Market divided into North America, Europe, Asia Pacific and Rest of the World. North America leads the global healthcare 3D printing market due to superior technology and high healthcare costs. However, Asia-Pacific is the fastest-growing area, owing to increasing healthcare investments, expanded medical infrastructure and rising demand for individualized medical solutions.

Key Players

• The Global Healthcare 3D Printing Market study report will provide valuable insight with an emphasis on the global market. The major players in the market are Cyfuse Biomedical, Aprecia Pharmaceuticals, Aspect Biosystems, Bio 3D Technologies, BioBots, 3Dynamics Systems, Envision TEC, Luxexel, Materialise NV, Nano3D Biosciences, Oceanz, Organovo Holdings, Inc., regenHU, Digilab.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

• Global Healthcare 3D Printing Market Recent Developments
• In November 2022, Evonik introduces three new INFINAM photopolymers for industrial 3D applications, expanding their photo-resins product portfolio. The product range is designed for use in standard UV-curing 3D printing techniques. The INFINAM RG 2000 L is a photo resin designed for the eyeglass industry.
• In June 2022, Belgian contract manufacturer Amnovis and medical device service provider BAAT Medical collaborated to deliver an innovative and quick turnaround procedure for 3D-printed medical equipment. Both Amnovis and BAAT Medical have experience 3D printing medical equipment for a variety of certified end-user applications.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL HEALTHCARE 3D PRINTING MARKET

• 1.1 Introduction of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL HEALTHCARE 3D PRINTING MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL HEALTHCARE 3D PRINTING MARKET, BY TECHNOLOGY

• 5.1 Overview
• 5.2 Syringe Based
• 5.3 Magnetic Levitation
• 5.4 Laser Based
• 5.5 Inkjet Based

6 GLOBAL HEALTHCARE 3D PRINTING MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Fused Deposition Modelling (FDM)
• 6.3 Selective Laser Sintering (SLS)
• 6.4 Stereolithography

7 GLOBAL HEALTHCARE 3D PRINTING MARKET, BY END-USER

• 7.1 Overview
• 7.2 Biosensors
• 7.3 Medical
• 7.4 Pharmaceuticals
• 7.5 Prosthetics and Implants
• 7.6 Tissue and Organ Generation
• 7.7 Dental

8 GLOBAL HEALTHCARE 3D PRINTING MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL HEALTHCARE 3D PRINTING MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Cyfuse Biomedical
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• Aprecia Pharmaceuticals
• Aspect Biosystems
• Bio 3D Technologies
• BioBots
• 3Dynamics Systems<
• Envision TEC
• Luxexel
• Materialise NV
• Nano3D Biosciences
• Oceanz
• Organovo Holdings, Inc.
• regenHU
• Digilab

12 Appendix

• 12.1 Related Research